Evidence map›Paper›PMID 32656444›Full record

ArticleACS omega2020

Ultrasmall Mixed Eu-Gd Oxide Nanoparticles for Multimodal Fluorescence and Magnetic Resonance Imaging of Passive Accumulation and Retention in TBI.

Badrul Alam Bony, Hunter A Miller, Aria W Tarudji, Connor C Gee, Anandakumar Sarella, Michael G Nichols, Forrest M Kievit

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Sex-based differences of antioxidant enzyme nanoparticle effects following traumatic brain injury.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Badrul Alam BonyDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, 3605 Fair Street, Lincoln, Nebraska 68583-0726, United States.
Hunter A MillerDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, 3605 Fair Street, Lincoln, Nebraska 68583-0726, United States.
Aria W TarudjiDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, 3605 Fair Street, Lincoln, Nebraska 68583-0726, United States.
Connor C GeeDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, 3605 Fair Street, Lincoln, Nebraska 68583-0726, United States.
Anandakumar SarellaNebraska Center for Materials and Nanoscience, University of Nebraska-Lincoln, 855 N 16th Street, Lincoln, Nebraska 68588-0298, United States.
Michael G NicholsDepartment of Physics, Creighton University, 2500 California Plaza, Omaha, Nebraska 68178, United States.
Forrest M KievitDepartment of Biological Systems Engineering, University of Nebraska-Lincoln, 3605 Fair Street, Lincoln, Nebraska 68583-0726, United States.
University of Nebraska–Lincoln · USCreighton University · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
ZINC FINGER-INSPIRED FLUORESCENT CHEMOSENSORSP20RR016469 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI EUDY, JAMES D · 2001 to 2011
$36.2M
Project 9 - Renal Drug Targeting for the Treatment of Lupus NephritisP20GM103480 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BRONICH, TATIANA K · 2012 to 2017
$13.3M
Nanoparticle-mediated reduction of oxidative stress for the treatment of traumatic brain injuryR01NS109488 · NINDS · UNIVERSITY OF NEBRASKA LINCOLN · PI KIEVIT, FORREST M · 2019 to 2023
$2.2M
NCRR NIH HHS P20 RR016469NIGMS NIH HHS P20 GM103427NIGMS NIH HHS P20 GM103480NINDS NIH HHS R01 NS109488
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. TBI can have a long-term impact on the quality of life for survivors of all ages. However, there remains no approved treatment that improves outcomes following TBI, which is partially due to poor delivery of therapies into the brain. Therefore, there is a significant unmet need to develop more effective delivery strategies that increase the accumulation and retention of potentially efficacious treatments in the injured brain. Recent work has revealed that nanoparticles (NPs) may offer a promising approach for site-specific delivery; however, a detailed understanding of the specific NP properties that promote brain accumulation and retention are still being developed. Multimodal imaging plays a vital role in the understanding of physicochemical properties that initiate the uptake and accumulation of NPs in the brain at both high spatial (e.g., fluorescence imaging) and temporal (e.g., magnetic resonance imaging, MRI) frequency. However, many NP systems that are currently used in TBI only provide contrast in a single imaging modality limiting the imaging data that can be obtained, and those that offer multimodal imaging capabilities have complicated multistep synthesis methods. Therefore, the goal of this work was to develop an ultrasmall NP with simple fabrication capable of multimodal imaging. Here, we describe the development, characterization, accumulation, and retention of poly(ethylene glycol) (PEG)-coated europium-gadolinium (Eu-Gd) mixed magnetic NPs (MNPs) in a controlled cortical impact mouse model of TBI. We find that these NPs having an ultrasmall core size of 2 nm and a small hydrodynamic size of 13.5 nm can be detected in both fluorescence and MR imaging modalities and rapidly accumulate and are retained in injured brain parenchyma. These NPs should allow for further testing of NP physicochemical properties that promote accumulation and retention in TBI and other disease models.

Identifiers

PMID32656444
PMCPMC7346268
OpenAlexW3037110521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.